treatment
Patients receiving treatment       with zafirlukast had degrees of nasal symptoms similar to those in the placebo       group, whereas the BDP group had significantly less symptoms compared with both       treatments (p = 0.01 and p = 0.005, respectively).
Patients receiving  @SUBJECT$         @PREDICAT$   @OBJECT$  had degrees of nasal symptoms similar to those in the placebo       group, whereas the BDP group had significantly less symptoms compared with both       treatments (p = 0.01 and p = 0.005, respectively).